Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

• Roch Houot,
• Viola Poeschel,
• Bettina Altmann,
• Stephanie Angel,
• Lorenz Thurner,
• Thomas Illmer,
• Marc Andre,
• Martin Dreyling,
• Hervé Maisonneuve,
• Hervé Tilly,
• Stephanie Mayer,
• Olivier Casasnovas,
• Steven Le Gouill,
• Fritz Offner,
• Guillaume Cartron,
• Andrea Kerkhoff,
• Thomas Weber,
• Joerg Hoffmann,
• Marita Ziepert,
• Wolfram Klapper,
• Emmanuel Itti,
• Dirk Hellwig,
• Giorgi Natchkebia,
• Laurence de Leval,
• Andreas Rosenwald,
• Corinne Haioun,
• Laurent Dercle,
• Philippe Gaulard,
• Gerhard Held

Affiliations

Roch Houot

1 Department of Hematology, CHU Rennes, University of Rennes, INSERM U1236, Rennes, France

Viola Poeschel

2 Department of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany

Bettina Altmann

3 Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Germany

Stephanie Angel

2 Department of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany

Lorenz Thurner

2 Department of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany

Thomas Illmer

4 Hematology-Oncology Practice, Dresden, Germany

Marc Andre

5 CHU UCL Namur, Yvoir, Belgium

Martin Dreyling

6 Department of Medicine III, LMU Hospital Munich, Germany

Hervé Maisonneuve

7 Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France

Hervé Tilly

8 Department of Hematology, Centre Henri Becquerel, Rouen, France

Stephanie Mayer

9 Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany

Olivier Casasnovas

10 Department of Hematology, CHU Dijon, Dijon, France

Steven Le Gouill

11 Department of Hematology, CHU Nantes, Nantes, France

Fritz Offner

12 University Hospital Ghent, Gent, Belgium

Guillaume Cartron

13 Department of Hematology, CHU Montpellier, Montpellier, France

Andrea Kerkhoff

14 Medizinische Klinik A, Hematology and Oncology, University Hospital Muenster, Germany

Thomas Weber

15 Department of Internal Medicine IV, Hematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

Joerg Hoffmann

16 Department of Hematology, Oncology and Immunology, Philipps University Marburg, University Hospital Giessen and Marburg, Germany

Marita Ziepert

17 Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Germany

Wolfram Klapper

18 Department of Pathology, Hematopathology Section, University of Schleswig-Holstein, Campus Kiel, Germany

Emmanuel Itti

19 Department of Nuclear Medicine, Henri Mondor University Hospitals, AP-HP/U-PEC, Créteil, France

Dirk Hellwig

20 Department of Nuclear Medicine, University Hospital Regensburg, Germany

Giorgi Natchkebia

21 Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany

Laurence de Leval

22 Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Switzerland

Andreas Rosenwald

23 Institute of Pathology, University of Würzburg, Germany

Corinne Haioun

24 Lymphoid Malignancies Unit, Henri Mondor University Hospital, APHP, Créteil, France

Laurent Dercle

25 Department of Radiology, Columbia University Irving Medical Center, New York, New York, USA

Philippe Gaulard

26 Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France

Gerhard Held

21 Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany